Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) kicked off on Monday, up 3.12% from the previous trading day, before settling in for the closing price of $34.89. Over the past 52 weeks, TNXP has traded in a range of $6.76-$130.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 73.03% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 93.08%. With a float of $7.35 million, this company’s outstanding shares have now reached $7.36 million.
In an organization with 81 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.58%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 93.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Take a look at Tonix Pharmaceuticals Holding Corp’s (TNXP) current performance indicators. Last quarter, stock had a quick ratio of 11.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2930.78, a number that is poised to hit -5.18 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Let’s dig in a bit further. During the last 5-days, its volume was 0.84 million. That was inferior than the volume of 1.31 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.45%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 77.84%, which indicates a significant increase from 62.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.84% in the past 14 days, which was lower than the 161.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.36, while its 200-day Moving Average is $21.87. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $36.86. Second resistance stands at $37.74. The third major resistance level sits at $39.15. If the price goes on to break the first support level at $34.57, it is likely to go to the next support level at $33.16. Assuming the price breaks the second support level, the third support level stands at $32.27.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
The company with the Market Capitalisation of 264.71 million has total of 7,357K Shares Outstanding. Its annual sales at the moment are 10,090 K in contrast with the sum of -130,040 K annual income. Company’s last quarter sales were recorded 2,430 K and last quarter income was -16,830 K.
